FDA escalates warning letters over misleading drug advertising
1. Thousands of warning letters and 100 cease and desist orders mark the most aggressive FDA enforcement in years. 2. ...
Tag: weight loss
Energy-reduced Mediterranean diet with increased physical activity may significantly reduce risk of type 2 diabetes
1. In this secondary analysis of a randomized controlled trial, physical activity paired with an ad libitum energy-reduced Mediterranean diet ...
Amycretin significantly improves weight loss in patients with overweight or obese body weight
1. The majority of treatment-related adverse events were mild-to-moderate gastrointestinal events with no reported deaths. 2. Amycretin resulted in significant ...
Very-low-calorie diets versus exercise alone for the treatement of hip osteoarthritis
1. In this randomized controlled trial, a very-low-calorie diet plus exercise was not superior to exercise alone in reducing hip ...
Tirzepatide-associated improvements in cardiometabolic risk factors linked to degree of weight loss
1. In this post-hoc analysis of the SURMOUNT-1 trial, there was a mostly linear relationship between percentage change in weight ...
Semaglutide may improve cardiovascular outcomes versus empagliflozin in patients with diabetes
1. In this retrospective cohort study, treatment with semaglutide resulted in nominally lower incidence of the composite of death, myocardial ...
Midlife weight loss is associated with decreased risk of mortality and chronic disease
1. Participants with sustained midlife weight loss from nonsurgical and nonpharmacological intervention had a decreased risk of chronic diseases beyond ...
Semaglutide improves walking ability in patients with peripheral artery disease and type 2 diabetes
1. Maximum walking distance at 52 weeks was significantly improved with semaglutide. 2. There were fewer treatment-related serious adverse events ...
4:3 intermittent fasting effective for weight loss among adults with obesity
1. In this randomized controlled trial, 4:3 intermittent fasting was associated with significantly greater weight loss compared with daily caloric ...
Glucagon-like peptide-1 receptor agonists and co-agonists safe and effective for weight loss
1. In this systematic review, glucagon-like peptide-1 receptor agonists and co-agonists were effective in inducing weight loss in overweight adults ...
